Targeted therapy is imperfect. 

​

Existing delivery technologies for nanoparticles in healthcare have challenges with precise targeting, toxicity, repeated administration and complexity in manufacturing, limiting the range of diseases that can be targeted. 

 

Our team members have lost loved ones to Pancreatic Cancer, and we are motivated to help others avoid such painful experiences. 

​

Our Technology: VLP (Virus-like Particles)

​

VLP Delivery Inc.'s vision is to research, develop and deploy virus-like particle technology as the gold standard, highly specific delivery vector for all types of cargo (genetic or non-genetic).